UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 76

Sortiert nach

RET-MAP: An International Multicenter Study on Clinicobiologic Features and Treatment Response in Patients With Lung Cancer Harboring a RET Fusion

Journal of thoracic oncology, 2023-05, Vol.18 (5), p.576-586

2023

Volltextzugriff (PDF)

Efficacy of chemotherapy for malignant pleural mesothelioma according to histology in a real-world cohort

Scientific reports, 2021-11, Vol.11 (1), p.21357-21357, Article 21357

2021

Volltextzugriff (PDF)

Molecular profiling of long‐term responders to immune checkpoint inhibitors in advanced non‐small cell lung cancer

Molecular oncology, 2021-04, Vol.15 (4), p.887-900

2021

Volltextzugriff (PDF)

Armenian Media System Overview According to the Hallin and Mancini Model

Media and communication (Lisboa), 2024-05, Vol.12 (5), p.1

2024

Volltextzugriff (PDF)

Current State-of-the-Art Therapy for Malignant Pleural Mesothelioma and Future Options Centered on Immunotherapy

Cancers, 2023-12, Vol.15 (24), p.5787

2023

Volltextzugriff (PDF)

Estudigramers: Influencers del aprendizaje

Comunicar (Huelva, Spain), 2020-01, Vol.28 (62), p.115-125

Spanish ed., 2020

Volltextzugriff (PDF)

Dynamic changes in circulating tumor DNA assessed by shallow whole‐genome sequencing associate with clinical efficacy of checkpoint inhibitors in NSCLC

Molecular oncology, 2023-05, Vol.17 (5), p.779-791

2023

Volltextzugriff (PDF)

Interrelations between Patients' Clinicopathological Characteristics and Their Association with Response to Immunotherapy in a Real-World Cohort of NSCLC Patients

Cancers, 2021-06, Vol.13 (13), p.3249

2021

Volltextzugriff (PDF)

Hepatic Rupture as the Initial Presentation of an EGFR -Mutated Lung Adenocarcinoma: A Case Report

Frontiers in oncology, 2022-03, Vol.12, p.837630

2022

Volltextzugriff (PDF)

High levels of chromosomal aberrations negatively associate with benefit to checkpoint inhibition in NSCLC

Journal for immunotherapy of cancer, 2022-04, Vol.10 (4), p.e004197

2022

Volltextzugriff (PDF)

Overview of Checkpoint Inhibitors Mechanism of Action: Role of Immune-Related Adverse Events and Their Treatment on Progression of Underlying Cancer

Frontiers in medicine, 2022-05, Vol.9, p.875974

2022

Volltextzugriff (PDF)

Studygrammers: Learning Influencers

Comunicar (Huelva, Spain), 2020, Vol.28 (62), p.111

2020

Volltextzugriff (PDF)

Studygrammers: Learning influencers

Comunicar (Huelva, Spain), 2020-01, Vol.28 (62), p.115-125

2020

Volltextzugriff (PDF)

Contribuciones científicas presentadas en los congresos de la Asociación Española de Investigación de la Comunicación

El profesional de la informacion, 2020, Vol.29 (4)

2020

Volltextzugriff (PDF)

Contribuciones científicas presentadas en los congresos de la Asociación Española de Investigación de la Comunicación (2007-2018)

El profesional de la informacion, 2020-08

2020

Volltextzugriff (PDF)

A two-step algorithm avoids corticosteroids in two-thirds of cancer patients with severe immune-mediated hepatitis due to immune checkpoint inhibitors

Journal of hepatology, 2023-06, Vol.78, p.S375-S376

2023

Volltextzugriff (PDF)

WED-263 - A two-step algorithm avoids corticosteroids in two-thirds of cancer patients with severe immune-mediated hepatitis due to immune checkpoint inhibitors

Journal of hepatology, 2023-06, Vol.78, p.S375-S376

2023

Volltextzugriff (PDF)

Analysis of chemotherapy efficacy according to histology in malignant pleural mesothelioma (MPM) patients (p)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e20563-e20563

2021

Volltextzugriff (PDF)

La mirada de las protagonistas en la investigación de género en comunicación y sus perfiles

Revista de la Asociación Española de Investigación de la Comunicación, 2021-02, Vol.8 (15), p.220-241

2021

Volltextzugriff (PDF)

T-cell infiltration in matched samples from malignant pleural mesothelioma (MPM) during evolution of disease

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e20595-e20595

2022

Volltextzugriff (PDF)

Dynamic changes in circulating tumor DNA assessed by shallow whole#8208;genome sequencing associate with clinical efficacy of checkpoint inhibitors in NSCLC

Molecular oncology, 2023-05, Vol.17 (5), p.779

2023

Volltextzugriff (PDF)

Genetic evolution to tyrosine kinase inhibitory therapy in patients with EGFR-mutated non-small-cell lung cancer

British journal of cancer, 2021-11, Vol.125 (11), p.1561-1569

2021

Volltextzugriff (PDF)

An algorithm based on immunotherapy discontinuation and liver biopsy spares corticosteroids in two thirds of cases of severe checkpoint inhibitor‐induced liver injury

Alimentary pharmacology & therapeutics, 2024-04, Vol.59 (7), p.865-876

2024

Volltextzugriff (PDF)

Genomic alterations profiling by liquid biopsy and their association to immune checkpoints inhibitors (ICI) response in a cohort of non-small cell lung cancer (NSCLC) patients

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e21524-e21524

2020

Volltextzugriff (PDF)

1 – 25 von 76

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(71)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

RET-MAP: An International Multicenter Study on Clinicobiologic Features and Treatment Response in Patients With Lung Cancer Harboring a RET Fusion

Efficacy of chemotherapy for malignant pleural mesothelioma according to histology in a real-world cohort

Molecular profiling of long‐term responders to immune checkpoint inhibitors in advanced non‐small cell lung cancer

Armenian Media System Overview According to the Hallin and Mancini Model

Current State-of-the-Art Therapy for Malignant Pleural Mesothelioma and Future Options Centered on Immunotherapy

Estudigramers: Influencers del aprendizaje

Dynamic changes in circulating tumor DNA assessed by shallow whole‐genome sequencing associate with clinical efficacy of checkpoint inhibitors in NSCLC

Interrelations between Patients' Clinicopathological Characteristics and Their Association with Response to Immunotherapy in a Real-World Cohort of NSCLC Patients

Hepatic Rupture as the Initial Presentation of an EGFR -Mutated Lung Adenocarcinoma: A Case Report

High levels of chromosomal aberrations negatively associate with benefit to checkpoint inhibition in NSCLC

Expression of TILs and Patterns of Gene Expression from Paired Samples of Malignant Pleural Mesothelioma (MPM) Patients

Overview of Checkpoint Inhibitors Mechanism of Action: Role of Immune-Related Adverse Events and Their Treatment on Progression of Underlying Cancer

Studygrammers: Learning Influencers

Studygrammers: Learning influencers

Contribuciones científicas presentadas en los congresos de la Asociación Española de Investigación de la Comunicación

Contribuciones científicas presentadas en los congresos de la Asociación Española de Investigación de la Comunicación (2007-2018)

A two-step algorithm avoids corticosteroids in two-thirds of cancer patients with severe immune-mediated hepatitis due to immune checkpoint inhibitors

WED-263 - A two-step algorithm avoids corticosteroids in two-thirds of cancer patients with severe immune-mediated hepatitis due to immune checkpoint inhibitors

Analysis of chemotherapy efficacy according to histology in malignant pleural mesothelioma (MPM) patients (p)

La mirada de las protagonistas en la investigación de género en comunicación y sus perfiles

T-cell infiltration in matched samples from malignant pleural mesothelioma (MPM) during evolution of disease

Dynamic changes in circulating tumor DNA assessed by shallow whole#8208;genome sequencing associate with clinical efficacy of checkpoint inhibitors in NSCLC

Genetic evolution to tyrosine kinase inhibitory therapy in patients with EGFR-mutated non-small-cell lung cancer

An algorithm based on immunotherapy discontinuation and liver biopsy spares corticosteroids in two thirds of cases of severe checkpoint inhibitor‐induced liver injury

Genomic alterations profiling by liquid biopsy and their association to immune checkpoints inhibitors (ICI) response in a cohort of non-small cell lung cancer (NSCLC) patients

Suchergebnisse filtern